ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, has entered into an agreement with Medtronic, Inc., a medical technology company, to collaborate on ARCA's proposed clinical trial, ...
[Published Zecco - May 01 2013]